NEWSLETTER 2019 / 3

 

The 3rd OcuTher Newsletter is under construction.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 722717.

 

          OCUTHER CONFERENCES & TRAINING ACTIVITIES

Courses and workshops are organized in connection with OcuTher events or scientific conferences in relevant fields.

2ND OCUTHER CONFERENCE - UNIVERSITY OF PADOVA, ITALY, 15.-17.10.2018

 

 

 

 

 

 

 

 

 

 

 

 

 

The OcuTher Padova conference included courses and workshops on:

  • Advanced Ophthalmology
  • Advanced Drug Discovery and Development
  • Workshops on ESR secondments, collaboration and education

3RD OCUTHER CONFERENCE - QUEEN'S UNIVERSITY BELFAST, U.K. 16.-18.9.2019

    
 

 

  

 

 

 

 

The OcuTher Belfast conference included courses on:

Business and Entrepreneurship

  • Advanced Course in Material Sciences
  • Personal Development Course
  • Scientific Publishing Course

More detailed information on this website under 'OcuTher Courses'.

JOINT ACTIVITIES

Further liaisons were formed with the topic related H2020-MSCA-ITN project IT-DED3 (Integrated Training in Dry Eye Disease Drug Development). The main objective of IT-DED3 is to deliver entrepreneurial and innovative researchers  able to face future challenges and to convert new ideas into therapeutic products for DED (Dry Eye Disease), generating both social and economic benefits. This is possible through the integration of expertise in medicinal chemistry, process chemistry, ocular drug delivery and formulation, ocular biology, in vitro and in vivo evaluation and imaging, biomarker research and clinical ophthalmology.

OcuTher and IT-DED3 ESRs took part in a joint satellite meeting prior to the EVER2019 Congress at Nice, France, 16.10.2019. The programme included invited speakers Prof. Morten Carstens Moe, Department of Ophthalmology, Division of Head, Neck and Reconstructive Surgery Oslo University Hospital and University of Oslo, Norway and Prof. Tor Paaske Utheim, Oslo Metropolitan University and Director of Innovation, Department of Ophthalmology, Oslo University Hospital, Norway and ESR presentation from both projects. This half-day event proved to be an excellent opportunity to get acquainted with PhD students from a similar MSCA-ITN project, therefore enhancing synergies with other initiatives and trigger external input that is valuable to all ESRs.

PROJECT DISSEMINATION

The project’s dissemination and exploitation strategy is to steer these activities in the second half of the project to maximize results. In the first half of the project the OcuTher consortium focused on awareness raising activities, as well as monitoring and ensuring the consistency of project external activities by organizing planned project events such as training workshops, conferences and courses. In compliance with the open-access policy of the EU, OcuTher is committed to disseminate its research results to a variety of stakeholders and to stimulate public engagement.

The OcuTher Twitter account #ocuther and the OcuTher LinkedIn group serve as a media for discussions throughout the project community and especially for networking between ESRs.

EVER2019 CONGRESS - NICE, FRANCE, 17.-19.10.2019

Ocuther took the opportunity to exhibit its   project results at one of the biggest European congresses on vision and eye research - EVER2019 (European Association for Vision and Eye Research) in Nice, France. This transnational two-day event was visited by almost one thousand representatives from scientific institutions, hospitals and industrial companies.

OcuTher shared an exhibition stand with two other EU-projects (IT-DED3 - MSCA-ITN funded project and the 'Ocular Drug Development Unit' - European Structural Fund-project), exhibiting ESR posters and project flyers.

This cost-effective dissemination allowed OcuTher ESRs to connect and network with colleagues and potential employers, also gaining more knowledge of their industry. It also increased OcuTher topic awareness and instigated numerous discussions with other scientists. The time spent at the EVER2019 Congress and the combined exhibition stand also strengthened the bond between ESRs and researchers from all three projects. While most of the today's business is conducted by email, face-to-face meetings are undeniably a fantastic way to get to know the researchers in your field. Such meetings are the most effective way to strengthen relationships with both prospective colleagues, but also future competitors. "Keep your friends close, but your competitors closer"......

The European Association for Vision and Eye Research (EVER) aims at encouraging the different aspects of research –basic, clinical and translational- concerning the eye and vision, and to promote mutual collaboration between different specialists and institutes involved in this field.

OcuTher contributed to this information exchange with its own session on 'PBP Prospects in retinal drug development'. The aim of this session was to highlight selected new developments in retinal drug development, including discovery and new retinal regenerative drugs, aspects of targeted drug delivery to the retina, and modelling tools for quantitative understanding of posterior segment pharmacokinetics and pharmacodynamics.